Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Healive + Sinovac varicella vaccine
- Development stage
- Unknown
- Lead developer
- Sinovac Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
Healive + Sinovac varicella vaccine refers to the co-administration regimen of two distinct vaccines developed by Sinovac Biotech and its subsidiary, Sinovac (Dalian) Vaccine Technology Co., Ltd. Healive is an inactivated hepatitis A vaccine derived from the H2 strain and adsorbed onto an aluminum hydroxide adjuvant, designed to provide active immunity against the hepatitis A virus. The varicella component is a live attenuated vaccine utilizing the Oka strain of the varicella-zoster virus (VZV) to prevent chickenpox. This combination is primarily evaluated in Phase IV clinical trials to assess the safety and immunogenicity of simultaneous administration in toddlers (aged 12-15 months), aiming to streamline pediatric vaccination schedules by administering both vaccines during a single visit at different injection sites.
- Other names
- Healive and varicella vaccine co-administrationSinovac Hepatitis A and Varicella vaccine combinationCombined immunization of inactivated hepatitis A vaccine and live attenuated varicella vaccine
02
Targets
Hepatitis A virus capsid protein
Beyond the preview
Go deeper on Healive + Sinovac varicella vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Healive + Sinovac varicella vaccine.